Lymph node metastasis of squamous cell carcinoma from an unknown primary: Impact of positron emission tomography

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 3, 2003, Pages 411-416

  Stoeckli, Sandro J ^a   Mosna Firlejczyk, Katarzyna ^a   Goerres, Gerhard W ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Neck metastasis; Panendoscopy; PET; Unknown primary

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; APPARATUS; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; FIBERSCOPE ENDOSCOPY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; LYMPH NODE METASTASIS; MALE; NECK METASTASIS; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; SWITZERLAND;

EID: 0037532537     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-1078-9     Document Type: Article

References (35)

1. Schapira DV, Jarrett AR. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma. Arch Intern Med 1995; 155: 2050-2054.
2. Hainsworth JD, Greco FA. Treatment of patients with cancer of an unknown primary site. N Engl J Med 1993; 329: 257-263.
3. Engzell U, Jacobsson PA, Sigurdson A, Zaijicek J. Aspiration biopsy of metastatic carcinoma in lymph nodes of the neck. Acta Otolaryngol 1971; 72:138-147.
4. Nordstrom DG, Tewfik HH, Latourette HB. Cervical lymph node metastases from an unknown primary. Radiat Oncol Biol Phys 1979; 5:73-76.
5. Knothe J, Fritsche F. Zur Halslymphknotenmetastasierung bei unbekanntem Primärtumor. Laryngol Rhinol Otol 1980; 59:221-226.
6. Leipzig B, Winter ML, Hokanson JA. Cervical node metastases of unknown origin. Laryngoscope 1981; 91:593-598.
7. Strasnick B, Moore DM, Abermayor E, Juillard G, Fu YS. Occult primary tumors. Arch Otolaryngol Head Neck Surg 1990; 116:173-176.
8. Wang RC, Goepfert H, Barber AE, Wolf P. Unknown primary squamous cell carcinoma metastatic to the neck. Arch Otolaryngol Head Neck Surg 1990; 116:1388-1393.
9. Subramanian R, Chilla R. Halslymphknotenmetastasen bei unbekanntem Primärtumor. HNO 1995; 43:299-303.
10. Martin HE, Morfit HM. Cervical lymph node metastases as the first symptom of cancer. Surg Gynecol Obstet 1944; 78: 133-159.
11. Muir C. Cancer of an unknown primary site. Cancer 1995; 75:353-356.
12. Abbruzzese JL, Raber MN. Unknown primary. In: Abeloff MF, Armitage JO, Lichter AS, et al., eds. Clinical oncology. New York: Churchill Livingstone; 1995:1833-1845.
13. Nowak B, Di Martino E, Jaenicke S, Cremerius U, Adam G, Zimny M, Reinartz P, Buell U. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI. Nuklearmedizin 1999; 38:312-318.
14. AAssar OS, Fischbein NJ, Caputo GR, Kaplan MJ, Price DC, Singer MI, Dillon WP, Hawkins RA. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors. Radiology 1999; 210:177-181.
15. Schipper JH, Schrader M, Arweiler D, Muller S, Sciuk J. Positron emission tomography for primary tumor detection in lymph node metastases with unknown primary tumor. HNO 1996; 44:254-257.
16. Greven KM, Keyes JW Jr, Williams DW 3rd, McGuirt WF, Joyce WT 3rd. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-d-glucose. Cancer 1999; 86:114-118.
17. Rege S, Maass A, Chaiken L, Hoh CK, Choi Y, Lufkin R, Anzai Y, Juillard G, Maddahi J, Phelps ME. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 1994; 73:3047-3058.
18. Hanasono MM, Kunda LD, Segall GM, Ku GH, Terris DJ. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 1999; 109:880-885.
19. Safa AA, Tran LM, Rege S, Brown CV, Mandelkern MA, Wang MB, Sadeghi A, Juillard G. The role of positron emission tomography in occult primary head and neck cancers. Cancer J Sci Am 1999; 5:214-218.
20. Bohuslavizki KH, Klutmann S, Sonnemann U, Thoms J, Kroger S, Werner JA, Mester J, Clausen M. F-18 FDG PET zur Detektion des okkulten Primärtumors bei Patienten mit Lymphknotenmetastasen der Halsregion. Laryngorhinootologie 1999; 78:445-449.
21. Bohuslavizki KH, Klutmann S, Kroger S, Sonnemann U, Buchert R, Werner JA, Mester J, Clausen M. FDG PET detection of unknown primary tumors. J Nucl Med 2000; 41: 816-822.
22. Lassen U, Daugaard G, Eigtved A, Damgaard K, Friberg L. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT). Eur J Cancer 1999; 35:1076-1082.
23. Braams JW, Pruim J, Kole AC, Nikkels PG, Vaalburg W, Vermey A, Roodenburg JL. Detection of unknown primary head and neck tumors by positron emission tomography. Int J Oral Maxillofac Surg 1997; 26:112-115.
24. Jungehulsing M, Scheidhauer K, Damm M, Pietrzyk U, Eckel H, Schicha H, Stennert E. 2[F]-fluoro-2-deoxy-d-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg 2000; 123:294-301.
25. Kole AC, Nieweg OE, Pruim J, Hoekstra HJ, Koops HS, Roodenburg JL, Vaalburg W, Vermey A. Detection of unknown occult primary tumors using positron emission tomography. Cancer 1998; 82:1160-1166.
26. Mukherji SK, Drane WE, Mancuso AA, Parsons JT, Mendenhall WM, Stringer S. Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-d-glucose SPECT. Radiology 1996; 199:761-766.
27. Mendenhall WM, Mancuso AA, Parsons JT, Stringer SP, Cassisi NJ. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck 1998; 20:739-744.
28. Stokkel MP, Terhaard CH, Hordijk GJ, van Rijk PP. The detection of unknown primary tumors in patients with cervical metastases by dual-head positron emission tomography. Oral Oncol 1999; 35:390-394.
29. Perie S, Talbot JN, Monceaux G, Grahek D, Kerrou K, Montravers F, St Guily JL. Use of a coincidence gamma camera to detect primary tumor with 18fluoro-2-deoxy-glucose in cervical lymph node metastases from an unknown origin. Ann Otol Rhinol Laryngol 2000; 109:755-760.
30. Reske SN, Kotzerke J. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000. Eur J Nucl Med 2001; 28:1707-1723.
31. Kostakoglu L, Wong JC, Barrington SF, Cronin BF, Dynes AM, Maisey MN. Speech-related visualization of laryngeal muscles with fluorine-18-FDG. J Nucl Med 1996; 37:1771-1773.
32. Kamel E, Hany TF, Burger C, Treyer V, Lonn AH, von Schulthess GK, Buck A. CT vs68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current. Eur J Nucl Med Mol Imaging 2002; 29:346-350.
33. Jones AS, Phillips DE, Helliwell TR, Roland NJ. Occult node metastases in head and neck squamous carcinoma. Eur Arch Otorhinolaryngol 1993; 250:446-449.
34. Minn H, Paul R, Ahonen A, et al. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18-fluorodeoxyglucose. J Nucl Med 1988; 29:1521-1525.
35. Zimny M, Wildberger JE, Cremerius U, Di Martino E, Jaenicke S, Nowak B, Buell U. Combined image interpretation of computed tomography and hybrid PET in head and neck cancer. Nuklearmedizin 2002; 41:14-21.